AVITA Medical, Inc. (RCEL) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AVITA Medical, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • AVITA Medical, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $63.3 M, a 12% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $63.3 M +$6.8 M +12% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $56.5 M +$5.21 M +10.1% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $51.3 M +$4.4 M +9.38% Dec 31, 2021 10-Q 2023-05-11
Q2 2021 $49.1 M +$7.18 M +17.1% Jun 30, 2021 10-K 2023-02-23
Q4 2020 $46.9 M Dec 31, 2020 10-Q 2022-11-10
Q2 2020 $41.9 M +$16 M +61.5% Jun 30, 2020 10-KT 2022-02-28
Q2 2019 $25.9 M Jun 30, 2019 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.